ID: ALA3359824

Max Phase: Preclinical

Molecular Formula: C38H60N6O6S

Molecular Weight: 729.00

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)c1nccs1)OC)N(C)C(=O)[C@@H](NC(=O)CNC)C(C)C

Standard InChI:  InChI=1S/C38H60N6O6S/c1-10-25(4)34(43(7)38(48)33(24(2)3)42-31(45)23-39-6)30(49-8)22-32(46)44-19-14-17-29(44)35(50-9)26(5)36(47)41-28(37-40-18-20-51-37)21-27-15-12-11-13-16-27/h11-13,15-16,18,20,24-26,28-30,33-35,39H,10,14,17,19,21-23H2,1-9H3,(H,41,47)(H,42,45)/t25-,26+,28-,29-,30+,33-,34-,35+/m0/s1

Standard InChI Key:  VGNDDFYOZUAKGZ-AHGVJVEKSA-N

Associated Targets(Human)

MDA-MB-361 612 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

NCI-N87 850 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

BT-474 2113 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 729.00Molecular Weight (Monoisotopic): 728.4295AlogP: 3.82#Rotatable Bonds: 20
Polar Surface Area: 142.20Molecular Species: BASEHBA: 9HBD: 3
#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 12.27CX Basic pKa: 8.50CX LogP: 3.23CX LogD: 2.09
Aromatic Rings: 2Heavy Atoms: 51QED Weighted: 0.19Np Likeness Score: 0.17

References

1. Maderna A, Doroski M, Subramanyam C, Porte A, Leverett CA, Vetelino BC, Chen Z, Risley H, Parris K, Pandit J, Varghese AH, Shanker S, Song C, Sukuru SC, Farley KA, Wagenaar MM, Shapiro MJ, Musto S, Lam MH, Loganzo F, O'Donnell CJ..  (2014)  Discovery of cytotoxic dolastatin 10 analogues with N-terminal modifications.,  57  (24): [PMID:25431858] [10.1021/jm501649k]

Source